Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REVIVA PHARMACEUTICALS HOLDINGS, INC. | Chief Financial Officer | Stock Option (right to buy) | 96.5K | Sep 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | Sep 15, 2024 | 1 | $0 | 4 | Sep 17, 2024 | Chief Financial Officer |
RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | Apr 25, 2023 | 1 | $0 | 4 | Apr 27, 2023 | Chief Financial Officer |
RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | Sep 30, 2022 | 1 | $83K | 4 | Oct 3, 2022 | Chief Financial Officer |
RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | Jun 30, 2022 | 1 | $60.7K | 4 | Jun 30, 2022 | Chief Financial Officer |